Less common, more critical The serious side effects listed in the safety warnings for semaglutide and tirzapetide include changes in vision, while tirzapetide lists the possibility of diabetic retinopathy complications
You might feel a dull throb at the site for several hours or even a day or two
Others report increased energy
nejm.org/doi/full/10.10 Long-awaited SURPASS-CVOT: Cardiovascular Outcomes with Tirzepatide vs Dulaglutide in NEJM: #tirzepatide noninferior to #dulaglutide for 3-point MACE in T2D with ASCVD, with greater improvements in weight, A1c, BP, triglycerides, and kidney function
However, the Food and Drug Administration (FDA) has not approved Mounjaro for weight loss, though doctors might prescribe it off-label